Somapacitan Mechanism Of Action
Somapacitan is under investigation in clinical trial NCT01706783 (A Trial Investigating the Safety, Tolerability, Availability and Distribution in the Body of Once-weekly Long-acting Growth Hormone (Somapacitan) Compared to Once Daily Norditropin NordiFlex® in Adults With Growth Hormone Deficiency). Abstract Somapacitan is a long‐acting growth hormone (GH) intended for once‐weekly subcutaneous administration. As for GH, the […]
